[1] He YQ, Gong XH, Zhang HL, Wang HY, Yang ZM. MeCP2 and neurodevelopmental disorders. Chin Bull Life Sci , 2012, 24(4): 374-379. 何艳琴, 公晓红, 张宏丽, 王红艳, 杨章民. MeCP2与神经发育性疾病. 生命科学, 2012, 24(4): 374-379.
[2] Amir RE, Van den Veyver IB, Wan MM, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MeCP2 , encoding methyl-CpG-binding protein 2. Nat Genet , 1999, 23(2): 185-188.
[3] Bhanushali AA, Mandsaurwala A, Das BR. Homozygous c. 1160C>T (P38L) in the MECP2 gene in a female Rett syndrome patient. J Clin Neurosci , 2016, 25: 127- 129.
[4] Mullaney BC, Johnston MV, Blue ME. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience , 2004, 123(4): 939-949.
[5] Kishi N, Macklis JD. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci , 2004, 27(3): 306-321.
[6] Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet , 2002, 11(2): 115-124.
[7] Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell , 1992, 69(6): 905- 914.
[8] Ghosh RP, Horowitz-Scherer RA, Nikitina T, Shlyakhtenko LS, Woodcock CL. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol Cell Biol , 2010, 30(19): 4656-4670.
[9] Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res , 1993, 21(21): 4886-4892.
[10] Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell , 2012, 151(7): 1417-1430.
[11] Wakefield RID, Smith BO, Nan XS, Free A, Soteriou A, Uhrin D, Bird AP, Barlow PN. The solution structure of the domain from MeCP2 that binds to methylated DNA. J Mol Biol , 1999, 291(5): 1055-1065.
[12] Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell , 2013, 152(5): 984-996.
[13] Chahrour M, Jung SY, Shaw C, Zhou XB, Wong STC, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science , 2008, 320(5880): 1224-1229.
[14] Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature , 2013, 493(7432): 327-337.
[15] Tao JF, Hu KP, Chang Q, Wu H, Sherman NE, Martinowich K, Klose RJ, Schanen C, Jaenisch R, Wang WD, Sun YE. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci USA , 2009, 106(12): 4882-4887.
[16] Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA , 2005, 102(49): 17551-17558.
[17] Guy J, Hendrich B, Holmes M, Martin JE, Bird A. A mouse MeCP2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet , 2001, 27(3): 322-326.
[18] Chen RZ, Akbarian S, Tudor M, Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet , 2001, 27(3): 327- 331.
[19] Shahbazian MD, Young JI, Yuva-Paylor LA, Spencer CM, Antalffy BA, Noebels JL, Armstrong DL, Paylor R, Zoghbi HY. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron , 2002, 35(2): 243-254.
[20] Liu Z, Zhou X, Zhu Y, Chen ZF, Yu B, Wang Y, Zhang CC, Nie YH, San
